How to Get Oral Micronized Progesterone in Texas

Why Oral Micronized Progesterone Matters for HRT in Texas

Any woman using estrogen-based hormone replacement therapy who still has a uterus needs a progestogen to prevent endometrial hyperplasia. The landmark PEPI trial (Postmenopausal Estrogen/Progestin Interventions, N=875) demonstrated that unopposed estrogen increased the rate of simple hyperplasia to 27.7% over three years, while adding oral micronized progesterone 200 mg cyclically reduced that rate to under 1% 1. That 1995 JAMA publication remains one of the most-cited references in menopause medicine.

Texas has roughly 2.8 million women between ages 45 and 64, according to U.S. Census estimates. A large proportion of those entering perimenopause or postmenopause may be candidates for combined HRT. The FDA-approved labeling for Prometrium specifically lists "prevention of endometrial hyperplasia in non-hysterectomized postmenopausal women who are receiving conjugated estrogens tablets" 2. Progesterone also carries an indication for secondary amenorrhea, broadening its clinical utility.

Texas law permits telehealth prescribing for non-controlled substances with a properly established patient-provider relationship. That means you do not need an in-person office visit to start progesterone therapy, though you will need labs drawn at a Texas-licensed facility.

Who Can Prescribe Progesterone in Texas

Four categories of clinicians hold prescriptive authority for oral micronized progesterone in Texas: physicians (MD/DO), nurse practitioners with prescriptive authority granted by the Texas Board of Nursing, physician assistants prescribing under a delegating physician, and certified nurse-midwives with prescriptive authority.

Texas removed the collaborative practice agreement requirement for experienced NPs in 2023 (HB 2prior legislative sessions retained supervision for PAs). NPs who have completed the required supervised practice hours can now independently prescribe non-controlled drugs, including progesterone.

The practical result: finding a prescriber is not difficult. Endocrinologists, OB/GYNs, family medicine physicians, and menopause-certified NPs all routinely prescribe micronized progesterone in Texas. The North American Menopause Society (NAMS) maintains a provider directory, and NAMS-certified menopause practitioners (NCMPs) are concentrated in the Dallas-Fort Worth, Houston, Austin, and San Antonio metro areas 3.

If you live in a rural part of Texas where menopause specialists are scarce, telehealth fills the gap. Platforms that employ Texas-licensed prescribers can evaluate symptoms, order labs electronically to a local Quest or Labcorp draw site, and transmit the prescription to any pharmacy you choose.

Step-by-Step: Getting Your Prescription via Telehealth

Getting oral micronized progesterone through a Texas telehealth provider follows a predictable sequence. Here is how it typically works.

Step 1: Initial consultation. You complete an intake form covering menopause symptoms, medical history, current medications, and any contraindications (active liver disease, known or suspected breast cancer, undiagnosed vaginal bleeding, or peanut allergy for the brand-name product). A licensed provider reviews the form and schedules a synchronous video or audio visit, which Texas law requires for prescribing 4.

Step 2: Lab work. Most clinicians order a baseline panel before starting HRT. Expect at minimum: follicle-stimulating hormone (FSH), estradiol, progesterone, complete metabolic panel (CMP), lipid panel, and CBC. Some providers add thyroid function tests and hemoglobin A1c depending on your risk profile. Labs are drawn at a Texas-licensed collection site or a mobile phlebotomy service.

Step 3: Prescription. Once labs confirm menopause status and rule out contraindications, the provider selects a dosing regimen. The Endocrine Society's 2015 clinical practice guideline recommends oral micronized progesterone 200 mg cyclically (12 to 14 days per month) or 100 mg continuously for endometrial protection 5. The prescription is e-prescribed to your pharmacy.

Step 4: Pharmacy fill. Retail pharmacies typically have generic micronized progesterone in stock. Compounding pharmacies may need 1 to 3 business days to prepare a custom formulation (useful if you need a peanut-oil-free base).

Step 5: Follow-up. Most providers schedule a follow-up visit at 8 to 12 weeks to assess symptom response, check for breakthrough bleeding, and review any side effects such as drowsiness, which is why the drug is dosed at bedtime.

Retail vs. Compounding Pharmacies in Texas

Texas has more than 5,000 licensed retail pharmacies and over 300 licensed compounding pharmacies. Both can fill a progesterone prescription, but they serve different needs.

Retail pharmacies (CVS, Walgreens, H-E-B Pharmacy, Walmart) dispense FDA-approved generic micronized progesterone capsules or brand-name Prometrium. GoodRx reports the average cash price for 30 capsules of generic progesterone 100 mg at Texas retail pharmacies is approximately $15 to $35 without insurance. The brand product, Prometrium, runs $150 to $250 for the same quantity without a coupon.

503A compounding pharmacies in Texas operate under the Texas State Board of Pharmacy's strict oversight. They can prepare custom progesterone formulations: capsules without peanut oil, sublingual troches, topical creams, or vaginal suppositories. This route is clinically relevant for women with peanut allergies, as the FDA label for Prometrium warns that the capsules contain peanut oil 2. A 503A pharmacy requires a patient-specific prescription and cannot distribute progesterone in bulk without one.

Texas does not permit 503B outsourcing facilities to ship compounded drugs directly to patients without a prescription. The Board of Pharmacy conducts routine inspections and requires pharmacies to report adverse events.

Insurance and Cost Considerations in Texas

Coverage for oral micronized progesterone varies sharply depending on your insurance plan. Commercial insurers in Texas, including Blue Cross Blue Shield of Texas, Aetna, UnitedHealthcare, and Cigna, generally cover generic micronized progesterone on Tier 1 or Tier 2 formularies when prescribed for an FDA-approved indication. Copays typically range from $0 to $25 for a 30-day supply.

Texas Medicaid does not cover progesterone for endometrial protection on HRT. Coverage is restricted to type 2 diabetes-related uses. Women on Texas Medicaid who need progesterone for menopause management will pay out of pocket or use manufacturer discount programs.

Medicare Part D plans vary. Most formularies include generic micronized progesterone, but prior authorization requirements differ by plan. The Centers for Medicare & Medicaid Services (CMS) reported that progesterone utilization among Part D enrollees increased 18% between 2020 and 2023 6.

For uninsured patients, several options reduce cost. GoodRx, RxSaver, and manufacturer coupons bring generic progesterone below $20 per month at most Texas pharmacies. The Prometrium brand offers a savings card reducing the copay to as low as $30 for commercially insured patients.

Prior Authorization: What Texas Patients Need to Know

Some insurance plans in Texas require prior authorization (PA) before covering oral micronized progesterone, especially if you are prescribed the brand-name Prometrium when a generic is available.

PA documentation typically requires three items: a confirmed diagnosis of postmenopausal status or secondary amenorrhea (ICD-10 codes N95.1 or N91.1), documentation that the patient has an intact uterus and is receiving concurrent estrogen therapy, and lab results supporting the clinical indication.

The Texas Department of Insurance requires insurers to process PA requests within 3 business days for non-urgent requests and 24 hours for urgent cases. If denied, you have the right to an independent review through the Texas Department of Insurance complaint process.

Brand-name Prometrium PA is more common than generic PA. If your insurer denies brand coverage, your provider can submit a letter of medical necessity citing peanut allergy or documented intolerance to the generic formulation's inactive ingredients. The American College of Obstetricians and Gynecologists (ACOG) supports the clinical use of micronized progesterone for endometrial protection on HRT and considers it preferable to synthetic progestins for many patients due to its more favorable metabolic profile 7.

Safety Profile and Monitoring

Oral micronized progesterone has a well-characterized safety profile from decades of use. The E3N French cohort study (N=80,377) found that estrogen combined with micronized progesterone did not significantly increase breast cancer risk over a mean follow-up of 8.1 years (RR 1.00 to 95% CI 0.83 to 1.22), while estrogen plus synthetic progestins carried a relative risk of 1.69 8.

The most common side effect is sedation. Progesterone's metabolite allopregnanolone acts on GABA-A receptors, producing a mild hypnotic effect. This is why the FDA label directs patients to take the capsule at bedtime. Dizziness, headache, and breast tenderness are reported in 5% to 10% of users 2.

Monitoring during progesterone therapy is straightforward. Your Texas provider will typically check a serum progesterone level 4 to 6 hours after a dose at the first follow-up to confirm adequate absorption. Annual visits should include a pelvic exam, assessment of bleeding patterns, and evaluation of whether continued HRT remains appropriate. The Endocrine Society recommends reassessing HRT at least annually, with shared decision-making about continuation 5.

Contraindications are absolute in some cases. Active liver disease, known thrombophilia with current VTE, and known or suspected progesterone-sensitive malignancies all preclude use. A history of depression requires careful monitoring, as some women report mood changes on progesterone, though the E3N data and PEPI trial did not identify depression as a statistically significant adverse event at standard HRT doses.

Transferring a Prescription to a Texas Pharmacy

If you already have an active progesterone prescription from an out-of-state provider, Texas law permits pharmacy-to-pharmacy transfers for non-controlled substances. Contact your new Texas pharmacy (retail or compounding) with the originating pharmacy's name, phone number, and your prescription number. The receiving pharmacist will verify the prescription and process the transfer, usually within 24 hours.

If your out-of-state provider wrote the original prescription, Texas pharmacies can fill it as long as the prescriber holds a license in good standing in their home state. Texas does not require the prescribing clinician to hold a Texas license for a one-time fill, but ongoing refills will require the prescriber to either obtain Texas licensure or refer you to a Texas-licensed provider.

For telehealth continuity, many multi-state platforms employ providers licensed in Texas and can simply re-establish your prescription under a Texas-licensed clinician, making the process smooth from your perspective.

Texas-Specific Regulatory Details

The Texas Medical Board and Texas Board of Nursing jointly oversee prescribing practices. Several state-level rules are worth knowing.

Texas permits audio-only telehealth visits for established patients under SB 670 provisions, but initial prescribing visits for HRT typically require a video component so the provider can conduct a visual assessment. The Texas Medical Board has not issued a specific prohibition on audio-only initial HRT consultations, but standard of care generally favors video.

The Texas State Board of Pharmacy updated its compounding regulations in 2024, aligning more closely with USP 795 and USP 797 standards. 503A pharmacies must now maintain beyond-use dating records for compounded progesterone preparations and cannot assign beyond-use dates exceeding the USP-recommended limits without stability testing data.

Texas does not classify progesterone as a controlled substance. It is not on any Texas Controlled Substances Act schedule, meaning there are no additional DEA-related barriers to prescribing, dispensing, or transferring.